Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Maedler

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Plos Computational Biology|August 29, 2014
Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategiesGang Zhao, Gitanjali Dharmadhikari, Kathrin Maedler, et al.
Expert Opinion on Biological Therapy|July 17, 2009
Interleukin-1 beta targeted therapy for type 2 diabetesKathrin Maedler, Gitanjali Dharmadhikari, Desiree M Schumann, et al.
Xenotransplantation|August 12, 2004
Expression of Fas but not Fas ligand on fetal pig beta cellsLijun Bai, Kathrin Maedler, Marc Donath, et al.
Handbook of Experimental Pharmacology|April 13, 2011
Interleukin-targeted therapy for metabolic syndrome and type 2 diabetesKathrin Maedler, Gitanjali Dharmadhikari, Desiree M Schumann, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetesMarc Y Donath, Joachim Størling, Kathrin Maedler, et al.
Cell Metabolism|December 26, 2017
mTORC1 Signaling: A Double-Edged Sword in Diabetic β CellsAmin Ardestani, Blaz Lupse, Yoshiaki Kido, et al.
Frontiers in Endocrinology|April 4, 2022
Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast CancerVasileios Angelis, Stephen R D Johnston, Amin Ardestani, et al.
Trends in Endocrinology and Metabolism: TEM|August 10, 2021
SARS-CoV-2 and pancreas: a potential pathological interaction?Shirin Geravandi, Azam Mahmoudi-Aznaveh, Zahra Azizi, et al.
Diabetes|February 28, 2003
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and functionKathrin Maedler, José Oberholzer, Pascal Bucher, et al.
Stem Cell Research & Therapy|July 26, 2022
Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?Zahra Azizi, Roya Abbaszadeh, Roxana Sahebnasagh, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Plos Computational Biology|August 29, 2014
Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategiesGang Zhao, Gitanjali Dharmadhikari, Kathrin Maedler, et al.
Expert Opinion on Biological Therapy|July 17, 2009
Interleukin-1 beta targeted therapy for type 2 diabetesKathrin Maedler, Gitanjali Dharmadhikari, Desiree M Schumann, et al.
Xenotransplantation|August 12, 2004
Expression of Fas but not Fas ligand on fetal pig beta cellsLijun Bai, Kathrin Maedler, Marc Donath, et al.
Handbook of Experimental Pharmacology|April 13, 2011
Interleukin-targeted therapy for metabolic syndrome and type 2 diabetesKathrin Maedler, Gitanjali Dharmadhikari, Desiree M Schumann, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetesMarc Y Donath, Joachim Størling, Kathrin Maedler, et al.
Cell Metabolism|December 26, 2017
mTORC1 Signaling: A Double-Edged Sword in Diabetic β CellsAmin Ardestani, Blaz Lupse, Yoshiaki Kido, et al.
Frontiers in Endocrinology|April 4, 2022
Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast CancerVasileios Angelis, Stephen R D Johnston, Amin Ardestani, et al.
Trends in Endocrinology and Metabolism: TEM|August 10, 2021
SARS-CoV-2 and pancreas: a potential pathological interaction?Shirin Geravandi, Azam Mahmoudi-Aznaveh, Zahra Azizi, et al.
Diabetes|February 28, 2003
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and functionKathrin Maedler, José Oberholzer, Pascal Bucher, et al.
Stem Cell Research & Therapy|July 26, 2022
Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?Zahra Azizi, Roya Abbaszadeh, Roxana Sahebnasagh, et al.
Pageof 10